Company profile for Sterna Biologicals

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Sterna Biologicals is a clinical-stage immunology company developing innovative therapies for chronic inflammatory diseases, including atopic dermatitis, ulcerative colitis, asthma, and COPD. Its lead candidate, hgd40, is a proprietary DNAzyme that targets GATA-3?a master transcription factor driving inflammation?thereby disrupting multiple inflammatory pathways. Sterna aims to deliver targeted, disease-modifying treatments fo...
Sterna Biologicals is a clinical-stage immunology company developing innovative therapies for chronic inflammatory diseases, including atopic dermatitis, ulcerative colitis, asthma, and COPD. Its lead candidate, hgd40, is a proprietary DNAzyme that targets GATA-3?a master transcription factor driving inflammation?thereby disrupting multiple inflammatory pathways. Sterna aims to deliver targeted, disease-modifying treatments for patients with high unmet medical needs.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Germany
Address
Address
Rudolf-Bultmann-Str. 4h, 35039 Marburg
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Arvo

Arvo

Not Confirmed

envelop Contact Supplier

Arvo

Post an Enquiry

Meeting

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty